Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.

Samat AHA. et al, (2024), Int J Cardiol, 415

Multiparametric CMR Evaluation of Myocardial Perfusion, Oxygenation, and Energetics in Hypertrophic Cardiomyopathy Following Cardiac Myosin Inhibitor Therapy.

Finnigan LEM. et al, (2024), European heart journal. Cardiovascular Imaging

Myocardial Disarray and Fibrosis across Hypertrophic Cardiomyopathy Stages Associate with ECG Markers of Arrhythmic Risk.

Ashkir Z. et al, (2024), Eur Heart J Cardiovasc Imaging

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.

Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684

Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.

Costello RE. et al, (2023), EClinicalMedicine, 61

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.

Zheng B. et al, (2023), Lancet Reg Health Eur, 29

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.

McAuley HJC. et al, (2023), EClinicalMedicine, 57

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.

Liew F. et al, (2023), EBioMedicine, 87

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.

PHOSP-COVID Collaborative Group None., (2022), Lancet Respir Med, 10, 761 - 775

Include forthcoming?